List View

By /

Clear

Displaying 701 - 725 of 2,995

Treatment Conundrums in Myeloma: Whats New in 2022?

Treatment Conundrums in Myeloma: Whats New in 2022?

B-Cell Lymphomas: Updates and Future Directions

B-Cell Lymphomas: Updates and Future Directions

Chronic Lymphocytic Leukemia: Practice Updates in Treatment-Naive and Relapse Disease

Chronic Lymphocytic Leukemia: Practice Updates in Treatment-Naive and Relapse Disease

Updates in Stem Cell Transplantation and CAR-T Therapy for Heme Malignancies

Updates in Stem Cell Transplantation and CAR-T Therapy for Heme Malignancies

Breast Cancer Immunotherapy

Breast Cancer Immunotherapy

The Management of HER2+ Breast Cancer: A Rapidly Changing Frontier

The Management of HER2+ Breast Cancer: A Rapidly Changing Frontier

Endocrine Therapy in the Neoadjuvant and Adjuvant Setting: ER+ HER-2 Normal Node Negative and Node Positive Breast Cancer

Endocrine Therapy in the Neoadjuvant and Adjuvant Setting: ER+ HER-2 Normal Node Negative and Node Positive Breast Cancer

Inhibiting CDK4/6, PIK3CA, and PARP in mBC

Inhibiting CDK4/6, PIK3CA, and PARP in mBC

Breast Cancer Cases

Breast Cancer Cases

Updates in Esophageal and Gastric Cancers

Updates in Esophageal and Gastric Cancers

What to do About ONJ in the Osteoporosis Patient?

What to do About ONJ in the Osteoporosis Patient?

What Lies Beyond EGFR, ALK And ROS1 Targeted Therapies?

What Lies Beyond EGFR, ALK And ROS1 Targeted Therapies?

Management of Thyroid and Thymic Carcinomas

Management of Thyroid and Thymic Carcinomas

Angiogenesis, mTor pathway, and other Therapeutics for Kidney Cancer

Angiogenesis, mTor pathway, and other Therapeutics for Kidney Cancer

Triple Negative Breast Cancer

Triple Negative Breast Cancer

Cancer and Thrombosis What is the Role of Direct Oral Anticoagulants?

Cancer and Thrombosis What is the Role of Direct Oral Anticoagulants?

The New Face of Oral Cancer

The New Face of Oral Cancer

Squamous Cell Carcinoma Standard and Novel Targets

Squamous Cell Carcinoma Standard and Novel Targets

Update on the Treatment of Small Cell Lung Cancer and Neuroendocrine Lung Cancers

Update on the Treatment of Small Cell Lung Cancer and Neuroendocrine Lung Cancers

Surfing Between Therapeutic Options For HRPC

Surfing Between Therapeutic Options For HRPC

Incorporating Immunotherapy and Novel Biological Agents in Breast Cancer: New Horizons

Incorporating Immunotherapy and Novel Biological Agents in Breast Cancer: New Horizons

How to Handle the Onco-Geriatric Patient: Facts and Myth

How to Handle the Onco-Geriatric Patient: Facts and Myth

Updates in the Management of HER-2 Positive Breast Cancer

Updates in the Management of HER-2 Positive Breast Cancer

ALK-Altered Non-Squamous NSCLC: Options and Sequence

ALK-Altered Non-Squamous NSCLC: Options and Sequence

EGFR: Common and Uncommon Mutations and What Is Next for This Patient Population

EGFR: Common and Uncommon Mutations and What Is Next for This Patient Population